GoHealth, Inc. (GOCOQ)
OTCMKTS · Delayed Price · Currency is USD
0.3500
+0.0150 (4.48%)
At close: Jun 18, 2026
GoHealth Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -554.11 | -497.76 | -7.32 | -151.27 | -376.38 | -534.19 |
Depreciation & Amortization | 53.94 | 80.11 | 105.89 | 105.75 | 107 | 107.51 |
Stock-Based Compensation | 8.94 | 9.17 | 11.28 | 19.55 | 27.14 | 27.3 |
Other Adjustments | 319.77 | 307.39 | -56.56 | 19 | 32.98 | 406.8 |
Change in Receivables | 154.16 | 132.83 | -53.53 | 125.09 | 243.85 | -455.71 |
Changes in Accounts Payable | -11.83 | -7.67 | -5.06 | 2.56 | -24.8 | 30.48 |
Changes in Accrued Expenses | -57.62 | -86.65 | 27.64 | 32.92 | 0.55 | 25.75 |
Changes in Unearned Revenue | 0.12 | -28.23 | 1.32 | 1.81 | 50.06 | -0.2 |
Changes in Other Operating Activities | -17.18 | -31.14 | -45.27 | -46.26 | 0.5 | 93.27 |
Operating Cash Flow | -102.56 | -121.95 | -21.61 | 109.14 | 60.9 | -299.01 |
Operating Cash Flow Growth | - | - | - | 79.20% | - | - |
Capital Expenditures | -5.2 | -8.25 | -13.73 | -13.73 | -13.51 | -19.8 |
Payments for Business Acquisitions | - | - | 17.54 | - | - | - |
Investing Cash Flow | -5.2 | -8.25 | 3.81 | -13.73 | -13.51 | -19.8 |
Long-Term Debt Issued | 108.75 | 138 | 558.25 | - | - | 565 |
Long-Term Debt Repaid | - | -2.38 | -556.05 | -15.34 | -160.27 | -298.97 |
Net Long-Term Debt Issued (Repaid) | 108.75 | 135.62 | 2.2 | -15.34 | -160.27 | 266.03 |
Issuance of Common Stock | - | 0 | 0.4 | 0.09 | 0.01 | - |
Repurchase of Common Stock | -4.42 | -5.22 | -1.51 | -2.3 | -0.35 | - |
Net Common Stock Issued (Repurchased) | -4.42 | -5.22 | -1.11 | -2.2 | -0.34 | - |
Issuance of Preferred Stock | - | - | - | - | 50 | - |
Net Preferred Stock Issued (Repurchased) | - | - | - | - | 50 | - |
Preferred Share Dividends Paid | - | - | - | -3.57 | - | - |
Other Financing Activities | -8.19 | -8.41 | -33.13 | - | -4.44 | -6.94 |
Financing Cash Flow | 125.17 | 122 | -32.03 | -21.11 | -115.05 | 259.09 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 0.32 | 0.18 | -0.06 | 0.04 | -0.24 | -0.16 |
Net Cash Flow | 17.73 | -8.02 | -49.89 | 74.35 | -67.9 | -59.87 |
Free Cash Flow | -107.76 | -130.2 | -35.34 | 95.41 | 47.39 | -318.81 |
Free Cash Flow Growth | - | - | - | 101.32% | - | - |
FCF Margin | -70.53% | -35.98% | -4.42% | 12.99% | 7.50% | -30.01% |
Free Cash Flow Per Share | -7.53 | -10.06 | -3.54 | 10.27 | 5.65 | -45.12 |
Levered Free Cash Flow | -218.91 | -203.33 | 70.07 | 4.45 | -189.17 | 313.67 |
Unlevered Free Cash Flow | -488.61 | -491.98 | 60.58 | 1.28 | -199.51 | -252.43 |